StonvexLoading…
StonvexStonvexStonvexCore line items from FSLR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.22B | $4.21B | $3.32B | $2.62B |
Operating Income | $1.60B | $1.39B | $857.27M | $-27.24M |
Net Income | $1.53B | $1.29B | $830.78M | $-44.17M |
EPS (Diluted) | $14.21 | $12.02 | $7.74 | $-0.41 |
Total Assets | $13.32B | $12.12B | $10.37B | $8.25B |
Total Liabilities | $3.78B | $4.15B | $3.68B | $2.42B |
Cash & Equivalents | $2.80B | $1.62B | $1.95B | $1.48B |
Free Cash Flow OCF − CapEx | $1.19B | $-308.08M | $-784.51M | $-30.24M |
Shares Outstanding | 107.31M | 107.06M | 106.85M | 106.61M |